Post-Surgery Accelerated Partial Breast Irradiation vs Whole-Breast Irradiation: QoL Outcomes

Share this content:
A previous analysis showed that APBI had non-inferior efficacy.
A previous analysis showed that APBI had non-inferior efficacy.

Accelerated partial breast irradiation (APBI) with multicatheter brachytherapy does not affect long-term quality of life (QoL) compared with whole-breast irradiation among patients with breast cancer who undergo breast-conserving surgery, according to a study published in The Lancet Oncology.1

For the phase 3 GEC-ESTRO study ( identifier: NCT00402519), investigators randomly assigned 1184 patients with early-stage breast cancer who underwent breast-conserving surgery to receive whole-breast irradiation or APBI using multicatheter brachytherapy. A previous analysis showed that APBI had non-inferior efficacy.

Patients completed the European Organisation for Research and Treatment of Cancer QLQ-C30 and breast cancer module QLQ-BR23 — 2 QoL questionnaires — before radiotherapy, immediately after radiotherapy, and during follow-up.

Overall, 633 patients underwent APBI and 551 patients received whole-breast irradiation. Fifty-three percent vs 57% of patients in the APBI group vs whole-breast irradiation group completed the QoL questionnaires before radiotherapy, respectively. Follow-up response rates were similar.

Global health status remained stable and did not differ significantly between the 2 groups. The APBI group had a mean global health status score of 65.5 and 66.2 before radiotherapy and after 5-years, respectively, while patients in the whole-breast irradiation group had mean scores of 64.6 and 66.

Patients undergoing whole-breast irradiation, however, reported significantly worse breast symptom scores immediately following radiotherapy (P < .0001) and after 3-month follow-up (P < .0001).

The authors concluded that this 5-year follow-up evidence “supports APBI as an alternative treatment option after breast-conserving surgery for patients with early breast cancer.”


  1. Schafer R, Strnad V, Polgar C, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018 Apr 22. doi: 10.1016/S1470-2045(18)30195-5

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs